User profiles for Julia R. Port
 | Julia R. PortVisiting fellow, Rocky Mountain Laboratories, NIAID, NIH Verified email at nih.gov Cited by 2500 |
Ecology, evolution and spillover of coronaviruses from bats
In the past two decades, three coronaviruses with ancestral origins in bats have emerged
and caused widespread outbreaks in humans, including severe acute respiratory syndrome …
and caused widespread outbreaks in humans, including severe acute respiratory syndrome …
[HTML][HTML] ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
…, R Rosenke, D Long, A Ishwarbhai, R Kailath… - Nature, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December
2019 1, 2 and is responsible for the coronavirus disease 2019 (COVID-19) pandemic 3. …
2019 1, 2 and is responsible for the coronavirus disease 2019 (COVID-19) pandemic 3. …
Atypical and unique transmission of monkeypox virus during the 2022 outbreak: an overview of the current state of knowledge
JC Riopelle, VJ Munster, JR Port - Viruses, 2022 - mdpi.com
An ongoing monkeypox outbreak in non-endemic countries has resulted in the declaration
of a public health emergency of international concern by the World Health Organization (WHO…
of a public health emergency of international concern by the World Health Organization (WHO…
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
…, T Bushmaker, A Carmody, JR Port… - Science translational …, 2021 - science.org
ChAdOx1 nCoV-19/AZD1222 is an approved adenovirus-based vaccine for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) currently being deployed globally. Previous …
respiratory syndrome coronavirus 2 (SARS-CoV-2) currently being deployed globally. Previous …
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
SARS-CoV-2 emerged in late 2019 and resulted in the ongoing COVID-19 pandemic.
Several animal models have been rapidly developed that recapitulate the asymptomatic to …
Several animal models have been rapidly developed that recapitulate the asymptomatic to …
SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters
Transmission of SARS-CoV-2 is driven by contact, fomite, and airborne transmission. The
relative contribution of different transmission routes remains subject to debate. Here, we show …
relative contribution of different transmission routes remains subject to debate. Here, we show …
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B. 1.351 and B. 1.1. 7
We investigated ChAdOx1 nCoV-19 (AZD1222) vaccine efficacy against SARS-CoV-2
variants of concern (VOCs) B.1.1.7 and B.1.351 in Syrian hamsters. We previously showed …
variants of concern (VOCs) B.1.1.7 and B.1.351 in Syrian hamsters. We previously showed …
Increased small particle aerosol transmission of B. 1.1. 7 compared with SARS-CoV-2 lineage A in vivo
The major transmission route for SARS-CoV-2 is airborne. However, previous studies could
not elucidate the contribution between large droplets and aerosol transmission of SARS-CoV…
not elucidate the contribution between large droplets and aerosol transmission of SARS-CoV…
[HTML][HTML] Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques
…, MG Holbrook, T Bushmaker, A Carmody, JR Port… - BioRxiv, 2021 - ncbi.nlm.nih.gov
Intramuscular vaccination with ChAdOx1 nCoV-19/AZD1222 protected rhesus macaques
against pneumonia but did not reduce shedding of SARS-CoV-2. Here we investigate whether …
against pneumonia but did not reduce shedding of SARS-CoV-2. Here we investigate whether …
Infection-or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters
Limited data is available on the effect of vaccination and previous virus exposure on the
nature of SARS-CoV-2 transmission and immune-pressure on variants. To understand the …
nature of SARS-CoV-2 transmission and immune-pressure on variants. To understand the …
